Most Recent

Oncologists have raised concerns about a mouse study that suggests the vaccine for human papillomavirus could cause brain damage.

0 Comments

image: Karolinska Finds Macchiarini Guilty of Misconduct

Karolinska Finds Macchiarini Guilty of Misconduct

By | December 22, 2016

The embattled thoracic surgeon is dealt another blow by his former employer, which is calling for the retraction of one of his papers on artificial esophagus research.

0 Comments

image: Top 10 Retractions of 2016

Top 10 Retractions of 2016

By | December 21, 2016

A look at this year’s most memorable retractions

2 Comments

image: Opinion: The Scientist’s Scarlet Letter

Opinion: The Scientist’s Scarlet Letter

By | December 16, 2016

Managing privacy protections and expectations in a misconduct proceeding

0 Comments

image: Mouse Immunology Paper Retracted

Mouse Immunology Paper Retracted

By | December 16, 2016

A finding of misconduct spurs the retraction of a Science paper claiming to have identified a protein in mice that boosted immunity to both viruses and cancer.

1 Comment

Lawyers involved discuss the latest twist in the ongoing litigation that pits pathologist Fazlul Sarkar against anonymous commenters on the post-publication peer review site.

1 Comment

image: Famed Mammalian Embryologist Dies

Famed Mammalian Embryologist Dies

By | December 2, 2016

Andrzej Tarkowski’s research laid the groundwork for future advances in cloning, stem cell research, and in vitro fertilization.

0 Comments

Court of Appeals denies a motion filed by ACLU lawyers to enter the full Wayne State University investigation of pathologist Fazlul Sarkar into the official case record.

0 Comments

image: How to Track Cell Lineages As They Develop

How to Track Cell Lineages As They Develop

By | December 1, 2016

Sequencing and gene-editing advances make tracing a cells journey throughout development easier than ever.

0 Comments

image: Oligonucleotide Therapeutics Near Approval

Oligonucleotide Therapeutics Near Approval

By | December 1, 2016

Successful late-stage clinical trials could mark the maturation of a new drug development platform, but the path to commercialization is not without hurdles.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham